|
Volumn 99, Issue 3, 2000, Pages 233-238
|
The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects
a a a a a |
Author keywords
G protein; Hypertension; Polymorphism; 1 adrenoceptor
|
Indexed keywords
ATENOLOL;
BETA 1 ADRENERGIC RECEPTOR;
BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
CYCLIC AMP;
G PROTEIN COUPLED RECEPTOR;
RECEPTOR SUBTYPE;
ADULT;
AGED;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
BETA ADRENERGIC RECEPTOR BLOCKING;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DNA POLYMORPHISM;
FEMALE;
GENE MUTATION;
GENETIC VARIABILITY;
GENOTYPE;
HEART RATE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
NUCLEOTIDE SEQUENCE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR GENE;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
|
EID: 0033821403
PISSN: 01435221
EISSN: None
Source Type: Journal
DOI: 10.1042/cs0990233 Document Type: Article |
Times cited : (122)
|
References (21)
|